◆ Higher spread, higher book than tighter priced SP deals ◆ Large French supply expected in the second half of year ◆ Small premium paid

◆ Deal comes amid competing supply from other European banks ◆ Both EuGB and ICMA green bond standards used ◆ Low new issue premium paid

◆ Have capital markets comprehended the heatwave? ◆ Which SSA issuers need to get it done this autumn ◆ Halcyon days for MTN, M&A and ECM bankers

‘A fair outcome’ for both issuer and investors achieved, stable spread to KfW proved invaluable

Bankers expect more currency diversification but the biggest wave of isusance may still be to come

◆ Germany agency jumps ahead of full SSA reopening next week ◆ Bankers impressed by book size, tightening achieved ◆ First-mover advantage, 'not much concession' needed

Investors pay little heed to alarming worsening of climate

Data centres and energy projects are giving loan bankers that rare experience - a buyer's market

Limited damage to securitized properties this year

Existing investors and sector specialists back logistics landlord’s push into tech

Deal the first Kuwaiti Sharia-compliant transaction closed with Chinese banks

Platform claims it can make documenting bonds much faster

New ECM head at UniCredit — NIB treasurer heads to SEB — Mills takes up newly created position at UBS

Banks providing reserve-based lending facilities to oil exploration companies are looking to sell these loans, usually held and refinanced as ultra-secure relationship products, at bargain basement prices.

There will probably have been quieter inductions into a new job. Nathan Piper has joined Investec as an equity researcher to cover upstream oil and gas.

Asia’s third online-only IPO was launched this week, confirming that virtual roadshows are a new normal for the region’s equity capital markets amid the Covid-19 pandemic. Companies elsewhere should take heed.

There has been much discussion since the financial world went into lockdown about how life in the capital markets will change once governments lift restrictions. Chief among those concerns has been whether the usual business of putting deals together needs to burn the Bacchanalian quantities of jet fuel and waste the many hours lurking around airports that capital markets air miles enthusiasts were doing before Covid-19 grounded them. If that is to change, borrowers and investors need to make it happen.

Akesobio, a Chinese biopharmaceutical firm, has launched an online-only roadshow for its up to HK$2.58bn ($332.9m) IPO amid numerous country-wide lockdowns globally to combat the Covid-19 coronavirus pandemic.

The issuance calendar between now and spring promises rain. Negative carry is the price of staying dry.

Growing likelihood investors will grant formal interest forbearance 

The latest AI-led hacks matched the risks regulators flagged almost six months ago, yet no regulatory framework is on the horizon

New $75m partnership to develop treatment for lymphoma was “catalyst for investors”

◆ Pharma company prints 5.3, 10 and 15 year bonds ◆ Biggest domestic corporate deal in Swiss francs this year ◆ Roche pushes pricing and size in shorter tranches

M&A could be much needed shot in the arm but dollars expected to dominate